The global active pharmaceutical ingredient market is expected to grow at a CAGR of 6.5% and to gather total estimation of USD 205.51 billion by 2020. Increasing incidence of life style and age related diseases, increasing prevalence of cancer across the world are driving the growth of the market. Factors such as stringent regulatory requirements and global economic recession may restrict market growth.
Complete report on active pharmaceutical ingredient market spread across 206 pages, profiling 10 major companies and supported with 121 tables and 56 figures is now available at http://www.rnrmarketresearch.com/active-pharmaceutical-ingredient-market-by-type-innovative-generic-type-of-synthesis-synthetic-biotech-type-of-manufacturer-captive-merchant-therapy-oncology-diabetes-orthopedic-cns-nephrology-ophthalmology-global-forecast-to-market-report.html .
The Active Pharmaceutical Ingredients market is categorized on the basis of type, type of manufacturer, type of synthesis, therapeutic area and region. Factors such as increasing incidence of life style and age related diseases, Increasing prevalence of cancer across the world, Technological advancements in the APIs Manufacturing, Emerging markets for biosimilar and increasing scope for Highly potent active ingredients are driving market growth. On the other hand, stringent regulatory guidelines and global economic recession may restrict market growth in the forecast period.
North America accounts for the highest share of the global APIs market. The overall technological advancements in this region coupled with factors like increase in lifestyle and age related disorders in this region, the increase in demand for specialty biological and specialty drugs and increasing government focus on generics following the implementation of the Patient Protection and Affordable Care Act is driving the growth of this market.
Apart from the comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted.
The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments; and levels of output in order to remain successful.
The top players in the active pharmaceutical ingredient market are Teva Pharmaceuticals limited (Israel), Sun Pharmaceuticals Industries Limited (India), Dr. Reddy’s Laboratories Ltd. (India), Aurobindo (India), Novartis International AG (Switzerland), Boehringer Ingelheim (Germany), Albemarle Corporation (U.S.), Sigma Aldrich (U.S.), Mylan (U.K.), Allergan plc. (Ireland) and others are profiles in this research report. Ask for a discount before order a copy of Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020 research report at http://www.rnrmarketresearch.com/contacts/discount?rname=426219 .
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
On a related note, another research titled Pharmaceutical Packaging Market Forecasts to 2020 says the overall was estimated around $56.9 billion in 2013, with the high share accounted by North America and Europe. The market by value is projected to grow at a CAGR of 6.50% from 2015 to 2020. The high growth is forecasted to be in the Asia-Pacific and RoW due to increasing government initiatives, emerging pharmaceutical market, growing contract manufacturing activities and rising population and increased spend on healthcare. Companies like Amcor (Australia), AptarGroup (U.S.), Becton, Dickinson & Company (U.S.), Rexam (U.K.), and SCHOTT AG (Germany) and others are also discussed in this research report available at http://www.rnrmarketresearch.com/pharmaceutical-packaging-market-by-packaging-type-plastic-bottles-blister-packs-caps-closures-ampoules-vials-and-others-raw-material-plastics-paper-paperboard-glass-aluminum-foils-and-market-report.html .
RnR Market Research
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
P: + 1 888 391 5441